AllianceBernstein
LRMR icon

AllianceBernstein’s Larimar Therapeutics LRMR Stock Holding History

AllianceBernstein’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Buy
108,220
+33,690
+45% +$134K ﹤0.01% 2730
2026
Q1 		$284K Hold
74,530
– – ﹤0.01% 2911
2025
Q4 		$284K Hold
74,530
– – ﹤0.01% 2938
2025
Q3 		$241K Buy
74,530
+12,150
+19% +$45.6K ﹤0.01% 3020
2025
Q2 		$180K Buy
62,380
+29,320
+89% +$67.9K ﹤0.01% 3076
2025
Q1 		$71.1K Hold
33,060
– – ﹤0.01% 3098
2024
Q4 		$128K Hold
33,060
– – ﹤0.01% 3100
2024
Q3 		$217K Buy
33,060
+5,270
+19% +$42.4K ﹤0.01% 3017
2024
Q2 		$201K Buy
+27,790
New +$213K ﹤0.01% 3035
2019
Q2 		– Sell
-875
Closed -$29K – 3176
2019
Q1 		$29K Hold
875
– – ﹤0.01% 3091
2018
Q4 		$52K Buy
+875
New +$86.4K ﹤0.01% 3055
2017
Q2 		– Sell
-925
Closed -$52K – 3162
2017
Q1 		$52K Hold
925
– – ﹤0.01% 2967
2016
Q4 		$35K Hold
925
– – ﹤0.01% 3003
2016
Q3 		$37K Sell
925
-667
-42% -$30.3K ﹤0.01% 2964
2016
Q2 		$114K Buy
+1,592
New +$126K ﹤0.01% 2899
2016
Q1 		– Sell
-1,295
Closed -$98K – 2923
2015
Q4 		$98K Sell
1,295
-342
-21% -$54.9K ﹤0.01% 2849
2015
Q3 		$627K Sell
1,637
-171
-9% -$77.1K ﹤0.01% 2400
2015
Q2 		$751K Buy
1,808
+1,133
+168% +$474K ﹤0.01% 2425
2015
Q1 		$321K Buy
+675
New +$320K ﹤0.01% 2651

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

AllianceBernstein's LRMR Position: Q2 2026 in Review

AllianceBernstein increased its Larimar Therapeutics (LRMR) stake by 45% in Q2 2026, buying an estimated $134K and bringing the position to 108,220 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #2730.

AllianceBernstein first reported a position in LRMR in Q1 2015 and has held it in 19 quarters since. The position peaked at $751K in Q2 2015. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • AllianceBernstein held 108,220 shares of Larimar Therapeutics worth $487K as of Q2 2026.
  • AllianceBernstein bought 33,690 Larimar Therapeutics shares in Q2 2026, an estimated $134K.
  • Larimar Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2730 holding.
  • AllianceBernstein first reported a position in Larimar Therapeutics in Q1 2015 and has held it in 19 quarters since.
  • AllianceBernstein's Larimar Therapeutics position peaked at $751K in Q2 2015.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.